# Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients

> **NCT03982238** · PHASE4 · COMPLETED · sponsor: **Majianhua** · enrollment: 74 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Insulin
- **DRUG:** Metformin
- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT03982238
- **Lead sponsor:** Majianhua
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-15
- **Primary completion:** 2019-11-15
- **Final completion:** 2019-12-31
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03982238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03982238, "Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03982238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*